Study: Only 50% of Canadian healthcare workers are vaccinated

A new analysis published in the Canadian Medical Association Journal shows that vaccination rates among healthcare workers in Canada are less than 50%, well below the level necessary for herd immunity.

By comparison, a September 2013 article in the Center for Disease Control and Prevention's Morbidity and Mortality Weekly Report found that vaccination rates among U.S. healthcare workers was 92.3% for physicians, 89.1% for pharmacists, 88.5% for nurse practitioners and physician assistants, and 84.8% for nurses.

According to the CDC, the estimated herd immunity threshold for many diseases is at least three-quarters of the population or more. For mumps, for example, 75% to 86% of the population needs to be vaccinated to achieve herd immunity. For polio, the estimate is 80% to 86%, while pertussis is 92% to 94%.

With recent outbreaks of vaccine preventable diseases in developed countries making headlines lately, vaccination of healthcare workers could have a positive impact on patient health.

The analysis points out that mandatory influenza vaccination as a condition of employment for healthcare workers or a requirement for these employees to wear a mask during flu season could contain rates of the virus, which has the most deleterious impact on infants, the elderly and immunocomprised people--individuals most likely to be in a hospital or other healthcare setting.

The journal article says many healthcare workers favor such condition-of-service influenza vaccination policies.

In the U.S., laws regarding vaccination for healthcare workers vary by state. In Canada, condition-of-service policies must comply with employment law, provincial human rights codes and the Canadian Charter of Rights and Freedoms. Condition-of-service policies that apply to unionized employees must be consistent with collective labor agreements.

- see the study abstract (sub. req.)
- read the press release

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.